TARALLO, Roberta
 Distribuzione geografica
Continente #
NA - Nord America 2303
EU - Europa 582
AS - Asia 296
Continente sconosciuto - Info sul continente non disponibili 3
AF - Africa 1
Totale 3185
Nazione #
US - Stati Uniti d'America 2300
IT - Italia 275
CN - Cina 195
UA - Ucraina 135
DE - Germania 63
SE - Svezia 57
TR - Turchia 54
VN - Vietnam 34
FI - Finlandia 25
IN - India 9
GB - Regno Unito 8
RU - Federazione Russa 7
FR - Francia 4
CA - Canada 3
CH - Svizzera 3
EU - Europa 3
IE - Irlanda 3
KR - Corea 2
NL - Olanda 2
CI - Costa d'Avorio 1
IL - Israele 1
JP - Giappone 1
Totale 3185
Città #
Ann Arbor 715
Chandler 314
Woodbridge 234
Princeton 225
Jacksonville 189
Wilmington 179
Houston 150
Salerno 115
Izmir 54
Andover 50
Beijing 40
Nanjing 40
Dearborn 36
Dong Ket 32
Naples 32
Boardman 30
Fairfield 27
Pellezzano 27
Shenyang 23
Hebei 18
Nürnberg 13
Changsha 11
Ashburn 10
Düsseldorf 9
Cambridge 8
Nanchang 8
Norwalk 8
Tianjin 8
Redwood City 7
Renton 7
Guangzhou 6
Jiaxing 6
Jinan 6
Pisa 6
Seattle 6
Falls Church 5
San Giorgio A Cremano 5
Zhengzhou 5
Arzano 4
Napoli 4
Southend 4
San Diego 3
Taizhou 3
Xian 3
Yellow Springs 3
Ahmedabad 2
Amsterdam 2
Brescia 2
Fremont 2
Hangzhou 2
Hanoi 2
Hefei 2
Indiana 2
Latina 2
Messina 2
Milan 2
Montréal 2
Sabaudia 2
Selargius 2
Taglio Di Po 2
Washington 2
Abidjan 1
Argenteuil 1
Bhubaneswar 1
Brindisi 1
Brusciano 1
Camerino 1
Campofelice Di Roccella 1
Castellabate 1
Changchun 1
Chungnam 1
Como 1
Dresden 1
Erlangen 1
Fisciano 1
Florence 1
Grugliasco 1
Haikou 1
Leawood 1
Marcianise 1
Menlo Park 1
Monteroni D'arbia 1
Montesarchio 1
Nagold 1
New Delhi 1
Ningbo 1
Padova 1
Parabiago 1
Pavia 1
Rome 1
Shenzhen 1
Spinea 1
Taiyuan 1
Tokyo 1
Toronto 1
Verona 1
Totale 2755
Nome #
iSmaRT: a toolkit for a comprehensive analysis of small RNA-Seq data 119
Identification of Genes Selectively Regulated in Human Hepatoma Cells by Treatment With Dyslipidemic Sera and PUFAs 116
Small non-coding RNA deregulation in endometrial carcinogenesis 109
New Insights on Estrogen Receptor Actions in Hormone-responsive Breast Cancer Cells by Interaction Proteomics 91
Post-transcriptional regulation of human breast cancer cell proteome by unliganded Estrogen Receptor beta via microRNAs. 91
Specific patterns of PIWI-interacting small noncoding RNA expression in dysplastic liver nodules and hepatocellular carcinoma 89
Global Analysis of Estrogen Receptor Beta Binding to Breast Cancer Cell Genome Reveals Extensive Interplay with Estrogen Receptor Alpha for Target Gene Regulation. 88
Effects of Oestrogen on MicroRNA Expression in Hormone-Responsive Breast Cancer Cells 88
Timed regulation of P-Element-Induced Wimpy Testis-interacting RNA expression during rat liver regeneration. 83
Phenytoin neurotoxicity in a child carrying new STXBP1 and CYP2C9 gene mutations. 82
Estrogen Receptor α Controls a Gene Network in Luminal-like Breast Cancer Cells Comprising Multiple Transcription Factors and microRNAs. 81
Identification of cytoplasmic proteins interacting with unliganded estrogen receptor α and β in human breast cancer cells 79
Estrogen receptor beta impacts hormone-induced alternative mRNA splicing in breast cancer cells 79
Direct regulation of microRNA biogenesis and expression by estrogen receptor beta in hormone-responsive breast cancer. 78
iMir: an integrated pipeline for high-throughput analysis of small non-coding RNA data obtained by smallRNA-Seq. 78
Carcinogenic risk and Bisphenol A exposure: A focus on molecular aspects in endoderm derived glands 76
Comparative analysis of nuclear estrogen receptor alpha and beta interactomes in breast cancer cells. 73
RNA sequencing identifies specific PIWI-interacting small non-coding RNA expression patterns in breast cancer. 73
Activating stimuli induce platelet microRNA modulation and proteome reorganisation 72
A large set of estrogen receptor beta-interacting proteins identified by tandem affinity purification in hormone-responsive human breast cancer cells nuclei. 70
The RNA-Binding Protein SYNCRIP Is a Component of the Hepatocyte Exosomal Machinery Controlling MicroRNA Sorting 70
The "busy life" of unliganded estrogen receptors 68
Quantitative mapping of RNA-mediated nuclear Estrogen Receptor β interactome in human breast cancer cells 68
Identification of proteins associated with ligand-activated estrogen receptor alpha in human breast cancer cell nuclei by tandem affinity purification and nanoLC-MS/MS. 63
Histone macroH2A1.2 promotes metabolic health and leanness by inhibiting adipogenesis 62
Exploiting a new strategy to induce immunogenic cell death to improve dendritic cell-based vaccines for lymphoma immunotherapy 62
PDGFR-alpha inhibits melanoma growth via CXCL10/IP-10: a multi-omics approach 61
Identification of a hormone-regulated dynamic actin network associated with estrogen receptor alpha in human breast cancer cell nuclei. 60
Expression and Function of Phosphodiesterase Type 5 in Human Breast Cancer Cell Lines and Tissues: Implications for Targeted Therapy 60
Molecular mechanisms of selective estrogen receptor modulator activity in human breast cancer cells: Identification of novel nuclear cofactors of antiestrogen-ERα complexes by interaction proteomics. 56
Lack of pathogenic mutations in six patients with MMPSI. 55
Quantitative expression profiling of highly degraded RNA from formalin-fixed, paraffin-embedded breast tumor biopsies by oligonucleotide microarrays. 53
Pesticide toxicogenomics across scales: In vitro transcriptome predicts mechanisms and outcomes of exposure in vivo 52
The nuclear receptor ERβ engages AGO2 in regulation of gene transcription, RNA splicing and RISC loading 51
Integrated Analysis of the Estrogen-Responsive Transcriptome and Estrogen Receptor (ER)-α Binding to Chromatin in Breast Cancer Cells. 45
Identification of long non‑coding RNA expression patterns useful for molecular‑based classification of type I endometrial cancers 43
Interaction Proteomics Identifies ERbeta Association with Chromatin Repressive Complexes to Inhibit Cholesterol Biosynthesis and Exert An Oncosuppressive Role in Triple-negative Breast Cancer 42
Inhibition of histone methyltransferase DOT1L silences ER gene and blocks proliferation of antiestrogen-resistant breast cancer cells 41
Relations of gut liver axis components and gut microbiota in obese children with fatty liver: A pilot study 41
Activation of Farnesoid X Receptor Impairs The Tumor-Promoting Function of Breast Cancer-Associated Fibroblasts 39
Identification of a novel truncating mutation in PALB2 gene by a multigene sequencing panel for mutational screening of breast cancer risk-associated and related genes 38
Uncoupling effects of estrogen receptor α on LKB1/AMPK interaction upon adiponectin exposure in breast cancer 35
Global View of Candidate Therapeutic Target Genes in Hormone-Responsive Breast Cancer 35
Integrated Analysis of Estrogen -Responsive Transcriptome and Estrogen Receptor alpha Binding to Chromatin in Breast Cancer Cells. 34
Small Non-Coding RNA Profiling Identifies miR-181a-5p as a Mediator of Estrogen Receptor Beta-Induced Inhibition of Cholesterol Biosynthesis in Triple-Negative Breast Cancer 34
Splicing of platelet resident pre-mRNAs upon activation by physiological stimuli results in functionally relevant proteome modifications. 32
Colchicine reduces platelet aggregation by modulating cytoskeleton rearrangement via inhibition of cofilin and LIM domain kinase 1 31
MicroRNA Regulation of the Hyper-Proliferative Phenotype of Vascular Smooth Muscle Cells in Diabetes Mellitus 30
Metabolic Regulation of Epigenetic Modifications and Cell Differentiation in Cancer 27
Leptin Signaling Contributes to Aromatase Inhibitor Resistant Breast Cancer Cell Growth and Activation of Macrophages 26
The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei 25
The Histone Methyltransferase DOT1L Is a Functional Component of Estrogen Receptor Alpha Signaling in Ovarian Cancer Cells 25
Identification of Antiestrogen-Bound Estrogen Receptor α Interactomes in Hormone-Responsive Human Breast Cancer Cell Nuclei 25
Molecular and Functional Characterization of the Somatic PIWIL1/piRNA Pathway in Colorectal Cancer Cells 24
Insights into the Role of Estrogen Receptor β in Triple-Negative Breast Cancer 24
Histone Methyltransferase DOT1L as a Promising Epigenetic Target for Treatment of Solid Tumors 23
An overview of candidate therapeutic target genes in ovarian cancer 22
HOME-BIO (sHOtgun MEtagenomic analysis of BIOlogical entities): a specific and comprehensive pipeline for metagenomic shotgun sequencing data analysis 22
WIND (Workflow for pIRNAs aNd beyonD): a strategy for in-depth analysis of small RNA-seq data 21
Higher integrin alpha 3 beta1 expression in papillary thyroid cancer is associated with worst outcome 19
Regulation of metabolic reprogramming by long non-coding rnas in cancer 14
Combinatorial targeting of a chromatin complex comprising Dot1L, menin and the tyrosine kinase BAZ1B reveals a new therapeutic vulnerability of endocrine therapy-resistant breast cancer 9
Identification of functional pathways and molecular signatures in neuroendocrine neoplasms by multi-omics analysis 5
Targeted molecular profiling of epithelial ovarian cancer from Italian BRCA wild-type patients with a BRCA and PARP pathways gene panel 5
Transcriptomic profiling of calcified aortic valves in clonal hematopoiesis of indeterminate potential carriers 3
Combinatorial targeting of menin and the histone methyltransferase DOT1L as a novel therapeutic strategy for treatment of chemotherapy-resistant ovarian cancer 2
Integration of miRNA:mRNA Co-Expression Revealed Crucial Mechanisms Modulated in Immunogenic Cancer Cell Death 1
Whole-Exome Sequencing Revealed New Candidate Genes for Human Dilated Cardiomyopathy 1
Totale 3399
Categoria #
all - tutte 5294
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5294


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/2018411 0000 0124 25167 2936624
2018/2019301 16221734 2061 1011 2317664
2019/2020500 104274113 3545 376 31786518
2020/2021375 11273910 3720 388 7894949
2021/2022421 14021 347 315 514965180
2022/2023454 6910040131 8529 00 0000
Totale 3399